(Q43789073)

26 November 2017

title

The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis (English)

1 reference

26 November 2017

Karussis D

1

1 reference

26 November 2017

Abramsky O

2

1 reference

26 November 2017

Grigoriadis N

3

1 reference

26 November 2017

Chapman J

4

1 reference

26 November 2017

Mizrachi-Koll R

5

1 reference

26 November 2017

Niv H

6

1 reference

26 November 2017

Kloog Y

7

1 reference

26 November 2017

language of work or name

1 reference

1 November 2001

1 reference

26 November 2017

number of pages

9

1 reference

Journal of Neuroimmunology

inferred from page(s)

published in

1 reference

26 November 2017

volume

120

1 reference

26 November 2017

issue

1-2

1 reference

26 November 2017

page(s)

1-9

1 reference

Stringent structural requirements for anti-Ras activity of S-prenyl analogues

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Proteins regulating Ras and its relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

p21ras is modified by a farnesyl isoprenoid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Autoimmunity, microbial immunity and the immunological homunculus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

MS: a CNS and systemic autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Dislodgment and accelerated degradation of Ras.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

All ras proteins are polyisoprenylated but only some are palmitoylated

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Novel Ras antagonist blocks human melanoma growth

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Immunomodulating therapeutic approaches for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Inhibition of the progression of multiple sclerosis by linomide is associated with upregulation of CD4+/CD45RA+ cells and downregulation of CD4+/CD45RO+ cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Relapsing experimental allergic encephalomyelitis. An autoimmune model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Farnesyl derivatives of rigid carboxylic acids-inhibitors of ras-dependent cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Selective Inhibition of Ras-dependent Cell Growth by Farnesylthiosalisylic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

1 reference

7 January 2021

Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Membrane interactions of a constitutively active GFP-Ki-Ras 4B and their role in signaling. Evidence from lateral mobility studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Analysis of the T-cell activation signaling pathway mediated by tyrosine kinases, protein kinase C, and Ras protein, which is modulated by intracellular cyclic AMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Distinct Ras effector pathways are involved in Fc epsilon R1 regulation of the transcriptional activity of Elk-1 and NFAT in mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

Second generation immune networks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900385-X

7 January 2021

10.1016/S0165-5728(01)00385-X

Identifiers

DOI

1 reference

26 November 2017

1 reference